REMEDI,
a company leading future medicine based on AI technology
REMEDI, a biotech startup, specializes in the discovery of
cell-penetrating peptides (CPPs) utilizaing its proprietary peptide libraray and AI technology.
We aspire to lead the way in fostering healthier lives for humanity by developing effective new medications targeting skin, metabolism, and age-related chronic illnesses.
General information
-
Name
REMEDI Co., Ltd.
-
CEO
Chanho Park
-
Establishment Date
06-Nov-20
-
Adress
#D-707, 30, Songdomirae-ro, Yeonsu-gu, Incheon
-
Business area
Medical and pharmaceutical research and development industry
-
Leading new delivery technology
-
Clear vision
-
Open mind
-
Passion and challenge